Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
about
Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures.Zoledronic acid in pediatric metabolic bone disorders.Management of Osteoporosis in Chronic Kidney Disease.How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly.
P2860
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
@en
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
@nl
type
label
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
@en
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
@nl
prefLabel
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
@en
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
@nl
P2860
P1433
P1476
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.
@en
P2093
Sohita Dhillon
P2860
P2888
P304
P356
10.1007/S40265-016-0662-4
P577
2016-11-18T00:00:00Z